Edition:
India

Dare Bioscience Inc (DARE.OQ)

DARE.OQ on NASDAQ Stock Exchange Capital Market

2.28USD
17 Jan 2018
Change (% chg)

$-0.09 (-3.80%)
Prev Close
$2.37
Open
$2.36
Day's High
$2.41
Day's Low
$2.26
Volume
5,879
Avg. Vol
5,244
52-wk High
$35.70
52-wk Low
$2.11

Chart for

About

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide... (more)
No analyst recommendations are available for .

Overall

Beta: 2.58
Market Cap(Mil.): $19.23
Shares Outstanding(Mil.): 6.05
Dividend: --
Yield (%): --

Financials

BRIEF-Dare Bioscience Says Entered Into Common Stock Sales Agreement

* DARE BIOSCIENCE SAYS ON JANUARY 4, 2018, CO ENTERED INTO COMMON STOCK SALES AGREEMENT - SEC FILING

04 Jan 2018

BRIEF-Daré Bioscience announces MoU with CONRAD for conduct of Ovaprene postcoital test clinical trial

* Daré Bioscience, Inc announces memorandum of understanding with Conrad for the conduct of the Ovaprene® postcoital test clinical trial

24 Jul 2017

Earnings vs. Estimates